Optimalisatie van de werkingsprocessen van het Bijzonder ... - KCE
Optimalisatie van de werkingsprocessen van het Bijzonder ... - KCE
Optimalisatie van de werkingsprocessen van het Bijzonder ... - KCE
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>KCE</strong> Reports 133 Special Solidarity Fund 205<br />
Name Active substance Indication CIP UCD Source<br />
Adagen Pega<strong>de</strong>mase bovine<br />
a type of SCID (severe combined immuno<strong>de</strong>ficiency<br />
syndrome) caused by the chronic <strong>de</strong>ficiency of the<br />
a<strong>de</strong>nosine <strong>de</strong>aminase (ADA) enzyme<br />
Vidaza Azacitidine myelodysplastic syndrome<br />
Ku<strong>van</strong><br />
sapropterin<br />
dihydrochlori<strong>de</strong><br />
Cellcept Mycophenolate mofetil<br />
phenylketonuria (PKU) - tetrahydrobiopterin <strong>de</strong>fiency<br />
auto immunology diseases - neophrotic syndromegreffe<br />
pulmonaire-greffe <strong>de</strong>s ilots <strong>de</strong> Langhermans<br />
Mabthera Rituximab Heamatologic oncology (leukemia - lymphoma)<br />
Avastin Bevacizumab<br />
brain tumors (glioblastoma) - eye disor<strong>de</strong>rs-cancer<br />
colon métatasé 2ième intention-tumeur <strong>de</strong> l'ovaire<br />
Not found= not reimbursed un<strong>de</strong>r the statutory Not found= not reimbursed un<strong>de</strong>r the<br />
health insurance (l'Assurance Maladie statutory health insurance (l'Assurance<br />
obligatoire)<br />
Maladie obligatoire)<br />
CIP: Médicament NON Remboursable aux<br />
Assurés Sociaux (A) / Agrées aux<br />
collectivités: sinds 01/2009<br />
CIP: Médicament NON Remboursable aux<br />
Assurés Sociaux (A) / Agrées aux<br />
collectivités: sinds 04/2009<br />
CIP: <strong>de</strong>pending on the product;<br />
Homologation Assurés Sociaux (A) - 100% -<br />
since 10/01/2006 (re-examined in 2013) +<br />
Homologation Collectivité C: since<br />
10/01/2006<br />
CIP: Médicament NON Remboursable aux<br />
Assurés Sociaux (A) / Agrées aux<br />
collectivités C: since 1998<br />
CIP: Médicament NON Remboursable aux<br />
Assurés Sociaux (A) / Agrées aux<br />
collectivités C: sinds 07/2005<br />
UCD: Rétrocession: 100% - sinds<br />
18/02/2009 - Médicament Non<br />
facturable en sus <strong>de</strong> la TAA<br />
UCD: Rétrocession: 65% (sinds<br />
24/04/2009) - Médicament Non<br />
facturable en sus <strong>de</strong> la TAA<br />
Not found= not reimbursed un<strong>de</strong>r the<br />
statutory health insurance (l'Assurance<br />
Maladie obligatoire)<br />
UCD: Rétrocession: 100% (since<br />
11/05/2005) - TAA: 11/05/2005<br />
UCD: Médicament Non Remboursable<br />
au titre <strong>de</strong> la rétrocession - TAA:<br />
09/2005<br />
Mrs. Isabelle Chenney +<br />
Nomenclature Assurance Maladie<br />
Mrs. Isabelle Chenney +<br />
Nomenclature Assurance Maladie<br />
Mrs. Isabelle Chenney +<br />
Nomenclature Assurance Maladie<br />
(Base <strong>de</strong>s médicament et<br />
informations tarifaires)<br />
Mrs. Isabelle Chenney +<br />
Nomenclature Assurance Maladie<br />
(Base <strong>de</strong>s médicament et<br />
informations tarifaires)<br />
Mrs. Isabelle Chenney +<br />
Nomenclature Assurance Maladie<br />
(Base <strong>de</strong>s médicament et<br />
informations tarifaires)<br />
Mrs. Isabelle Chenney +<br />
Nomenclature Assurance Maladie<br />
(Base <strong>de</strong>s médicament et<br />
informations tarifaires)<br />
Bi-myconase and/or sucraid<br />
Ointmenst, disinfectants,<br />
glucamylase & invertase<br />
(saccharase)<br />
enzyme <strong>de</strong>ficiency sucrose isomaltase Not found in the nomenclature Not found in the nomenclature No information found<br />
painkillers, tape, food<br />
supplements<br />
epi<strong>de</strong>rmolysis bullosa - ichthyosis Not found in the nomenclature Not found in the nomenclature No information found<br />
Implantable cardiac valves<br />
(aortic valves)<br />
<strong>de</strong>generative valve disease (aged persons) Not found in the nomenclature Not found in the nomenclature No information found<br />
Implantable pulmonary valves congenital cardiac malformations (children)<br />
Patients who have no remaining auditory nerves (ex.<br />
Not found in the nomenclature Not found in the nomenclature No information found<br />
Brainstem implant<br />
Bilateral vestibular schwannomas tumors on both<br />
balance nerves)<br />
Not found in the nomenclature Not found in the nomenclature No information found<br />
Not found= not reimbursed un<strong>de</strong>r the statutory Not found= not reimbursed un<strong>de</strong>r the Nomenclature Assurance Maladie:<br />
Neuro stimulator of the stomach Severe gastro paresis<br />
health insurance (l'Assurance Maladie statutory health insurance (l'Assurance Liste <strong>de</strong>s prestations et <strong>de</strong>s Services<br />
obligatoire)<br />
Maladie obligatoire)<br />
(LPP)<br />
Flolan époprosténol pulmonary hypertension<br />
CIP: Médicament NON Remboursable aux<br />
Assurés Sociaux (A) / Agrées aux<br />
collectivités<br />
UCD: Rétrocession: 100% (sinds<br />
1/05/2004) - TAA: 05/2005<br />
Mrs. Isabelle Chenney +<br />
Nomenclature Assurance Maladie<br />
(Base <strong>de</strong>s médicament et<br />
informations tarifaires)<br />
Legen<strong>de</strong><br />
CIP (Club Inter Pharmaceutique):<br />
remboursables aux assurés sociaux<br />
et agréés aux collectivités (maisons<br />
<strong>de</strong> rétraites, hôpitaux)<br />
UCD (unités communes <strong>de</strong><br />
dispensation): rétrocédés et<br />
facturables en sus <strong>de</strong>s GHS par les<br />
établissements <strong>de</strong> santé